title: Boys will be boys: fathers' perspectives on ADHD symptoms, diagnosis, and drug treatment.
abstract: Fathers tend to be largely absent from research and clinical settings related to attention-deficit/hyperactivity disorder (ADHD), as well as from public forums related to ADHD, such as educational conferences and parent support groups. Because of these absences, little is known about fathers' perspectives on ADHD symptoms, diagnosis, and drug treatment. This article presents findings from a qualitative study involving 39 mothers and 22 fathers of boys with ADHD. In-depth interviews were conducted with participants using a picture-based method that elicited detailed narratives. Results of this study suggest that fathers' perspectives on ADHD behaviors, diagnosis, and drug treatment can be categorized along two dimensions: "reluctant believers" and "tolerant nonbelievers." Across these two dimensions, several related factors are relevant to fathers' perspectives: resistance to a medical framework for understanding their sons' behaviors; identification with the sons' symptomatic behaviors; and resistance to drug treatment with stimulants. These factors may help to explain, in turn, fathers' absences from clinical evaluations of their sons' behaviors. The study affirms the importance of fathers' perspectives to the clinical evaluation and treatment of boys' symptomatic behaviors.
authors.affiliation: Centre for Family Research, Faculty of Social and Political Sciences, University of Cambridge, CB2 3RF, England. iasingh@msn.com
authors.forename: Ilina
authors.initials: I
authors.lastname: Singh
mesh_terms: D000328:Adult; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis* / Q000188:drug therapy / Q000523:psychology; D001294:Attitude to Health; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002648:Child; D005220:Fathers; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000627:therapeutic use*
chemical_list: D000697:Central Nervous System Stimulants; D008774:Methylphenidate